DE60013586D1 - Genexpressions-basensequenzen zur therapeutischen anwendung und heilmittel zur gentherapie - Google Patents

Genexpressions-basensequenzen zur therapeutischen anwendung und heilmittel zur gentherapie

Info

Publication number
DE60013586D1
DE60013586D1 DE60013586T DE60013586T DE60013586D1 DE 60013586 D1 DE60013586 D1 DE 60013586D1 DE 60013586 T DE60013586 T DE 60013586T DE 60013586 T DE60013586 T DE 60013586T DE 60013586 D1 DE60013586 D1 DE 60013586D1
Authority
DE
Germany
Prior art keywords
gentherapy
gene expression
base sequences
therapeutic application
healing agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60013586T
Other languages
English (en)
Other versions
DE60013586T2 (de
Inventor
Kazuhiro Yuda
Katsuhiko Akiyama
Takeshi Goto
Katsuyuki Hamada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hisamitsu Pharmaceutical Co Inc
Original Assignee
Hisamitsu Pharmaceutical Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co Inc filed Critical Hisamitsu Pharmaceutical Co Inc
Application granted granted Critical
Publication of DE60013586D1 publication Critical patent/DE60013586D1/de
Publication of DE60013586T2 publication Critical patent/DE60013586T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4731—Recognins, e.g. malignin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60013586T 1999-04-02 2000-03-31 Genexpressions-basensequenzen zur therapeutischen anwendung und heilmittel zur gentherapie Expired - Fee Related DE60013586T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP9635899 1999-04-02
JP9635899 1999-04-02
PCT/JP2000/002102 WO2000060068A1 (fr) 1999-04-02 2000-03-31 Sequences de bases d'expression genique utilisees a des fins therapeutiques et medicaments utilises en therapie genique

Publications (2)

Publication Number Publication Date
DE60013586D1 true DE60013586D1 (de) 2004-10-14
DE60013586T2 DE60013586T2 (de) 2005-02-03

Family

ID=14162782

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60013586T Expired - Fee Related DE60013586T2 (de) 1999-04-02 2000-03-31 Genexpressions-basensequenzen zur therapeutischen anwendung und heilmittel zur gentherapie

Country Status (7)

Country Link
US (1) US6815430B1 (de)
EP (1) EP1174501B1 (de)
KR (1) KR100636578B1 (de)
AT (1) ATE275629T1 (de)
CA (1) CA2365545A1 (de)
DE (1) DE60013586T2 (de)
WO (1) WO2000060068A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5858601B2 (ja) * 2010-08-24 2016-02-10 花王株式会社 シミ関連遺伝子

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9214857D0 (en) * 1992-07-13 1992-08-26 Medical Res Council Human nucleic acid fragments and their use
US5728379A (en) * 1994-06-23 1998-03-17 Georgetown University Tumor- or cell-specific herpes simplex virus replication
US20030026789A1 (en) 1995-05-03 2003-02-06 Richard J. Gregory Gene therapy using replication competent targeted adenoviral vectors
DE19525900C1 (de) 1995-07-15 1996-12-12 Max Planck Gesellschaft Leberspezifischer Adenovirus-Expressionsvektor
JPH0928378A (ja) 1995-07-17 1997-02-04 Soosei:Kk 神経細胞特異的に発現するアデノウイルスベクター
GB9616685D0 (en) 1995-10-02 1996-09-25 Cancer Res Campaign Tech Antitumour vector constructs and methods
DE19704301C1 (de) 1997-02-06 1998-03-26 Hoechst Ag Der Promotor des humanen Endoglingens und seine Verwendung für die Gentherapie
EP0893493A3 (de) 1997-07-21 2002-12-04 Aventis Pharma Deutschland GmbH Genetisch veränderte Zellen und deren Verwendung in der Prophylaxe oder Therapie von Erkrankungen

Also Published As

Publication number Publication date
EP1174501A4 (de) 2002-07-03
DE60013586T2 (de) 2005-02-03
WO2000060068A1 (fr) 2000-10-12
CA2365545A1 (en) 2000-10-12
KR100636578B1 (ko) 2006-10-19
EP1174501B1 (de) 2004-09-08
EP1174501A1 (de) 2002-01-23
US6815430B1 (en) 2004-11-09
ATE275629T1 (de) 2004-09-15
KR20010112930A (ko) 2001-12-22

Similar Documents

Publication Publication Date Title
PT1042305E (pt) Inibicao de quinase p38 utilizando difenilureias simetricas e assimetricas
PT1019040E (pt) Inibicao da actividade de p38-quinase por meio de arilureias
IL161591A (en) Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
HUT76258A (en) Compositions comprising dna damaging agents and p53, and methods for uses thereof
HK1026691A1 (en) Substituted benzimidazoles and their use for treating retroviral infection
DE69840909D1 (de) Analoge von kokain
ES2154253T1 (es) Inhibicion de la actividad de la quinasa p38 utilizando ureas heterociclicas sustituidas.
TR199901949T2 (xx) Lemfositik t�m�rler i�in �areler.
DE69635349D1 (de) Nukleotidsequenzen, proteine, medikamente und diagnoseagentien zur anwendung in krebsbehandlung
IL132933A0 (en) Composition for the treatment of diarrheal disease
DE69631381D1 (de) Therapeutische und diagnostische agenzien zur behandlung mikrobieller infektionen
DE60237791D1 (de) Zytokinproteinfamilie
DE69625682D1 (de) Verfahren zur behandlung von entzündungen und zusammensetzungen dafür
ATE391186T1 (de) Gezielte verabreichung von kuenstlichen genen
DE60013586D1 (de) Genexpressions-basensequenzen zur therapeutischen anwendung und heilmittel zur gentherapie
MX9604762A (es) Nuevas sulfonamidas y procedimiento para su preparacion.
SE9700244D0 (sv) Novel antibacterial protein
MXPA01007952A (es) Formulaciones a base de l-arginina para tratar enfermedades, y metodos para usarlas.
DK1007085T3 (da) Anvendelse af væksthormon i præparater til behandling af insulin-resistens i hjertet
BR0206918A (pt) Uso de iloperidona
DK1092427T3 (da) Anvendelse af et peptid, der forebygger hudintolerancereaktioner, især i kosmetiske præparater
SE9803623D0 (sv) New therapeutic application
WO2001028582A3 (en) Therapeutic applications of flint polypeptides
AU2002225994A1 (en) Use of blood coagulation factor xiii for treating haemophilia
BR9708720A (pt) Composição farmacêutica e processo para o tratamento de demência por hiv.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee